# Sildenafil

NDC: 68001-363
Generic name: Sildenafil
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20180914
Marketing ended: 20271031
FDA application: ANDA203814

## Active ingredients

- SILDENAFIL CITRATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-363"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-363
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=be6d1015-306d-44fb-8d4d-01724b8d9590